The purpose of this paper is to provide reference for improving the incentive policies of innovative drug research and development in China. Taking Takeda Pharmaceutical Co., Ltd. as an empirical research object, and on the basis of combing Japan's innovative drug R&D incentive policies in terms of R&D support, registration review and approval, intellectual property rights and drug pricing, this paper analyzes how relevant policies encourage enterprises to innovate and develop from the aspects of mechanism and implementation effect. The results show that Takeda Pharmaceutical has achieved innovation transformation under a series of supports of innovative drug research and development incentive policies in Japan. In order to improve the related incentive policy in China, our country should learn from Japan's experience and take incentive measures, such as enhancing the commercial development of scientific research achievements, perfecting the intellectual property financing system, establishing and perfecting the drug data protection system and perfecting the price formation mechanism of innovative drugs.
| 科 Family | 属数 Number of genus | 种数 Number of species | 占总种数比例 Percentage of total species (%) | 属 Genus | 种数 Number of species | 占总种数比例 Percentage of total species (%) |
|---|---|---|---|---|---|---|
| 鹅膏菌科Amanitaceae | 2 | 11 | 5.26 | 鹅膏菌属 Amanita | 10 | 4.78 |
| 小菇科 Mycenaceae | 2 | 12 | 5.74 | 丝盖伞属 Inocybe | 5 | 2.39 |
| 多孔菌科 Polyporaceae | 8 | 14 | 6.70 | 蜡蘑属 Laccaria | 5 | 2.39 |
| 红菇科 Russulaceae | 3 | 23 | 11.00 | 小皮伞属 Marasmius | 6 | 2.87 |
| 小菇属 Mycena | 11 | 5.26 | ||||
| 光柄菇属 Pluteus | 5 | 2.39 | ||||
| 红菇属 Russula | 17 | 8.13 | ||||
| 栓菌属 Trametes | 5 | 2.39 |